Mechanism: Calcium Traffic Control
K2 MK-7's primary function is activating vitamin K-dependent proteins (VKDPs) outside the liver:
- Osteocalcin: Produced by osteoblasts; when activated by K2, binds calcium to hydroxyapatite crystals in bone matrix—increasing bone mineral density
- Matrix Gla Protein (MGP): Most potent known inhibitor of vascular calcification; requires K2 for carboxylation and activation; inactive MGP directly leads to arterial calcium deposits
- Protein S: Anti-clotting protein that also requires K2
- Growth Arrest Specific 6 (Gas6): Cell survival and apoptosis regulation
MK-7 is preferred over MK-4: with a half-life of ~72 hours (vs 1–2 hours for MK-4), once-daily MK-7 maintains stable active K2 levels in tissues.
K2 and Arterial Calcification
Coronary artery disease is the leading cause of death in India. Arterial calcification—calcium hardening of arteries—is a key predictor of cardiovascular events independent of LDL cholesterol. The Rotterdam Study (4807 adults) found high K2 intake associated with 52% lower severe aortic calcification and 57% lower CVD mortality. K2 supplementation in clinical trials reduces undercarboxylated MGP (a marker of K2 deficiency) and some studies show regression of existing arterial calcification with 360mcg/day.
Vitamin D3 dramatically increases intestinal calcium absorption—a good thing for bone mineralisation, a potentially bad thing without K2. K2 is required to activate the proteins that ensure absorbed calcium goes to bones rather than arteries. Anyone taking D3 at 2000IU+ should co-supplement K2 MK-7 90–200mcg. This pairing is particularly relevant in India given widespread D3 supplementation (due to the deficiency epidemic) and the high burden of cardiovascular disease. Indian vegetarian diets provide very little K2 (found mainly in natto, fermented cheeses).
Dosing Guide
| Population | Recommended Dose | Rationale |
|---|---|---|
| General prevention (under 40) | 90mcg/day | Adequate MGP activation for vascular protection |
| Taking D3 supplements | 100–200mcg/day | Manage increased calcium absorption |
| Bone health / over 50 | 180–200mcg/day | Maximum osteocalcin activation |
| Cardiovascular risk reduction | 200–360mcg/day | Trials showing MGP normalisation use these doses |
| Warfarin users | AVOID without medical advice | Interferes with anticoagulation |
Vitamin K in any form reduces the effectiveness of warfarin (Warf, Acitrom in India) and other vitamin K antagonist anticoagulants. If you take warfarin for atrial fibrillation, mechanical heart valves, DVT, or any other reason, consult your cardiologist or haematologist before taking any K2 supplement. Do not start K2 supplementation without medical supervision if you're on these medications. K2 does NOT interact with newer anticoagulants (rivaroxaban, apixaban, dabigatran) which work independently of vitamin K.
India Context
Indian vegetarian diets are particularly K2-deficient: natto (the richest K2 source at 1000mcg/100g) is not consumed in India; aged European cheeses (high K2) are rarely eaten; and fermented Indian foods like idli/dosa are primarily K1, not K2. The combination of vegetarian diet + widespread D3 supplementation + high cardiovascular disease burden makes K2 supplementation especially valuable for Indian adults. Cost in India: ~₹800–1500/month for 100–200mcg MK-7 from reputable brands (Solgar, Jarrow, Indian brands like Carbamide Forte).
Frequently Asked Questions
What is the difference between K1 and K2?
K1 primarily activates liver clotting factors. K2 activates extrahepatic proteins: osteocalcin (bones) and MGP (artery walls). MK-7 has a ~72-hour half-life enabling once-daily dosing and consistent tissue activation.
Should I take K2 with vitamin D3?
Yes—this is one of the most important nutrient pairings. D3 increases calcium absorption; K2 directs that calcium to bones rather than arteries. Standard pairing: 2000–5000IU D3 + 90–200mcg K2 MK-7 daily. Take with a fat-containing meal (both are fat-soluble).
Does K2 conflict with blood thinners?
Yes—K2 reduces warfarin efficacy. Anyone on warfarin or acenocoumarol (Acitrom) must consult their doctor. K2 is safe with newer anticoagulants (rivaroxaban, apixaban, dabigatran) which work via different mechanisms.
Can K2 reverse arterial calcification?
Some human studies show regression of coronary calcification with high-dose K2 (360mcg/day MK-7 for 2+ years). While impressive, this is not yet established as standard of care. K2 supplementation reliably normalises undercarboxylated MGP (a calcification marker). Prevention is better established than reversal.